nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Breast cancer susceptibility—A new look at an old model
|
Peto, Julian |
|
2002 |
1 |
5 |
p. 411-412 2 p. |
artikel |
2 |
Critical role for Gab2 in transformation by BCR/ABL
|
Sattler, Martin |
|
2002 |
1 |
5 |
p. 479-492 14 p. |
artikel |
3 |
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
|
Kelly, Louise M |
|
2002 |
1 |
5 |
p. 421-432 12 p. |
artikel |
4 |
EGF receptor activation by heterologous mechanisms
|
Carraway III, Kermit L |
|
2002 |
1 |
5 |
p. 405-406 2 p. |
artikel |
5 |
EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma
|
Liu, David |
|
2002 |
1 |
5 |
p. 445-457 13 p. |
artikel |
6 |
Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia
|
Sawyers, Charles L |
|
2002 |
1 |
5 |
p. 413-415 3 p. |
artikel |
7 |
Focus on acute leukemias
|
Gilliland, D.Gary |
|
2002 |
1 |
5 |
p. 417-420 4 p. |
artikel |
8 |
HIF activation identifies early lesions in VHL kidneys
|
Mandriota, Stefano J |
|
2002 |
1 |
5 |
p. 459-468 10 p. |
artikel |
9 |
HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions
|
Heinen, Christopher D. |
|
2002 |
1 |
5 |
p. 469-478 10 p. |
artikel |
10 |
Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
|
Weisberg, Ellen |
|
2002 |
1 |
5 |
p. 433-443 11 p. |
artikel |
11 |
Myc—Is this the oncogene from Hell?
|
Soucek, Laura |
|
2002 |
1 |
5 |
p. 406-408 3 p. |
artikel |
12 |
p53 stabilization is decreased upon NFκB activation
|
Tergaonkar, Vinay |
|
2002 |
1 |
5 |
p. 493-503 11 p. |
artikel |
13 |
Thinking beyond the tumor cell: Nf1 haploinsufficiency in the tumor environment
|
McLaughlin, Margaret E |
|
2002 |
1 |
5 |
p. 408-410 3 p. |
artikel |